Overview

Concurrent Chemoradiotherapy for Cervical Cancer in Elderly Women

Status:
Unknown status
Trial end date:
2014-03-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to evaluate the efficiency and safety of weekly Cisplatin /Liposome paclitaxel concurrent chemoradiothrapy in the treatment of locally advanced cervical cancer in elderly women.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Health Science Center of Xi'an Jiaotong University
Health Science Center of Xi’an Jiaotong University
Treatments:
Albumin-Bound Paclitaxel
Cisplatin
Paclitaxel
Criteria
Inclusion Criteria:

1. Histologically proven squamous carcinoma of cervix

2. FIGO stageⅡB and ⅢB

3. Over 65 years

4. Do not receive other treatment

5. Performance index ECOG grade 0 to 2

6. Normal ECG

7. Normal hematological parameters

8. Normal renal and liver function tests

Exclusion Criteria:

1. Concomitant disease which may adversely affect the outcome

2. Poor nutritional status

3. Medical or psychological condition precluding treatment

4. Previous treatment

5. Concurrent treatment for any cancer